Blog
Our blog regularly presents new articles on topics such as strategy, marketing and sales, analyses and market research, communication, and further education.
Market Insights
We analyze the healthcare and pharmaceutical market to create the basis for successful corporate and product strategies. Professional market research with its diverse quantitative and qualitative research tools provides the best basis to achieve this.
Series of events: ‘Marketing Stimuli at the POS/Pharmacy – from Patient to Consumer’
The series of events arranged by iMi salesmarketing and the Dr. Erkens Consulting Group has been very popular with participants for a number of years.
Adress
Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de
Social
News
Dr. Erkens Consulting Group
- Website-Relaunch of Dr. Erkens Consulting Group
Source: Dr. Erkens Consulting Group 09/2020 - Integrated Pharma-News at Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020
Pharma Letter
- Catalent to support Galapagos’ decentralized cell therapy approach
- Dermal pharmacology: challenges facing generic topical and transdermal drug development
- CAR-T patent filings peaking, law firm finds
- Arvinas looks for new chief commercial officer
- J&J’s Spravato first approval as monotherapy for treatment-resistant depression
Pharma Relations
Pharma Times
- AlzeCure’s NeuroRestore ACD856 to be presented at AD/PD 2025
- EC approves lazertinib in combination with amivantamab for NSCLC patients
- UK sees 70% increase in phase I advanced therapy clinical trials in 2024
- Datapharm expands into US market through partnership with phactMI
- Biofidelity and CellCarta partner to deploy Aspyre Lung in global clinical trials
PZ online
- Coesfeld: NRW-Ministerpräsident Wüst besucht Apotheke
- Fieber bei Kindern: Nicht nur die Temperatur zählt
- TI-Messenger : CompuGroup Medical erhält Zulassung
- Bankenabend: Krieg, Frieden und Zeitenwende: Worauf sich Europa einstellen muss
- Verschreibungspflicht: Sildenafil bleibt rezeptpflichtig, Naloxon-Nasenspray nicht
Our Place on Earth
Kartenbild: OpenStreetMap, ODbL 1.0